Lexicon Pharmaceuticals
LXRX
#6539
Rank
$0.91 B
Marketcap
$2.06
Share price
-3.95%
Change (1 day)
82.74%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - P/B ratio

P/B ratio as of September 2026 : 4.72

According to Lexicon Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 13.7366.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Lexicon Pharmaceuticals - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-313.85101.11%
2024-12-311.92-52.4%
2023-12-314.0230.77%
2022-12-313.08-40.41%
2021-12-315.1666.88%
2020-12-313.09-17.83%
2019-12-313.77-114.14%
2018-12-31-26.6-274.31%
2017-12-3115.367.18%
2016-12-319.1489.45%
2015-12-314.82107.92%
2014-12-312.32-57.26%
2013-12-315.4327.86%
2012-12-314.25190.06%
2011-12-311.46-25.57%
2010-12-311.977.66%
2009-12-311.8386.81%
2008-12-310.9780-32.38%
2007-12-311.45-55.97%
2006-12-313.2919.62%
2005-12-312.75-32.18%
2004-12-314.0581.88%
2003-12-312.2352.71%
2002-12-311.46

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Thermo Fisher Scientific
TMO
4.30-8.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
11.6 145.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
2.65-43.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-6.16-230.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
5.76 22.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-2.66-156.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
2.01-57.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
0.6836-85.50%๐Ÿ‡บ๐Ÿ‡ธ USA